alpha1at therapy used treatment alpha1at deficiency proposed therapy cigarette emphysema efficacy therapy unproven optimal route delivery alpha1at lung interstitium crucial locus action unknown created transgenic mice expression human alpha1at gene directed human surfactant protein c spc promoter fragment rat clara cell protein cc10 promoter fragment order examine ability pulmonary epithelial cell expression alpha1at deliver protein interstitium produce model allow studies efficacy alpha1at preventing lung damage cigarette smoke exposure transgenic lines studied situ hybridization light microscopic immunohistochemistry showed cc10 driven lines expressed human alpha1at type NUMBER alveolar cells airway epithelial cells alpha1at expression seen alveolar parenchyma spc driven lines small airway epithelium spc lines electron microscopic immunochemistry showed presence human alpha1at protein interstitium lines mean levels human protein varied NUMBER NUMBER lung protein serum levels NUMBER NUMBER compared normal human serum alpha1at levels conclude expression alpha1at pulmonary epithelial cells results diffuse expression transgene alveolar parenchyma reproducibly leads transfer protein interstitium present model limited low levels protein production limited protein production problem forms gene therapy relatively large amounts extracellular protein needed lung therapeutic effect alpha1 antitrypsin smoke induced NUMBER kda NUMBER NUMBER transgene mediated microg g microg ml mg ml